Back to top
more

Sanofi-aventis: (SNY)

(Market Close from NYSE)

 Add to portfolio

Save at Trade

$49.43 USD

49.43
454,138

+0.15 (0.30%)

Updated Aug 31, 2015 03:57 PM ET

Volume: 454,138

Open: $49.41

Prior Close: $49.28

Zacks Rank : 3-Hold [?]     3    

Style Scores [?] : Growth: B | Value: B | Momentum: A

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.

General Information

SANOFI-AVENTIS

54 RUE LA BOETIE

PARIS, I0 75008

Phone: 33-1-53-77-44-00

Fax: 33-1-53-77-42-96

Web: http://www.sanofi.com

Email: ir@sanofi.com

Industry LARGE CAP PHARMA
Sector Medical
Fiscal Year End December
Last Reported Quarter 6/30/2015
Next EPS Date 10/27/2015

EPS Information

Current Quarter EPS Consensus Estimate 0.87
Current Year EPS Consensus Estimate 3.14
Estimated Long-Term EPS Growth Rate 7.90
Next EPS Report Date 10/27/2015

Price and Volume Information

Zacks Rank
Yesterday's Close 49.28
52 Week High 57.42
52 Week Low 43.57
Beta 1.16
20 Day Moving Average 1,424,553.13
Target Price Consensus 60.50

SNY

% Price Change
4 Week -8.53
12 Week -1.17
YTD 8.05
% Price Change Relative to S&P 500
4 Week -2.69
12 Week 4.20
YTD 13.74
Share Information
Shares Outstanding (millions) 2,622.05
Market Capitalization (millions) 128,270.59
Short Ratio 1.92
Last Split Date NA
Dividend Information
Dividend Yield 2.22%
Annual Dividend $1.09
Payout Ratio 0.34
Change in Payout Ratio -0.01
Last Dividend Payout / Amount NA / $NA

Fundamental Ratios

P/E
P/E (F1) 15.57
Trailing 12 Months 15.10
PEG Ratio 1.97
EPS Growth
vs. Previous Year 8.33%
vs. Previous Quarter 6.85%
   
Sales Growth
vs. Previous Year -4.10%
vs. Previous Quarter 6.08%
   
Price Ratios
Price/Book 2.04
Price/Cash Flow 10.04
Price / Sales 3.08
ROE
6/30/15 12.36
3/31/15 11.69
12/31/14 12.01
ROA
6/30/15 7.15
3/31/15 6.71
12/31/14 6.90
Current Ratio
6/30/15 1.35
3/31/15 NA
12/31/14 1.80
Quick Ratio
6/30/15 0.91
3/31/15 NA
12/31/14 1.29
Operating Margin
6/30/15 20.39
3/31/15 20.23
12/31/14 20.25
Net Margin
6/30/15 13.48
3/31/15 12.39
12/31/14 12.93
Pre-Tax Margin
6/30/15 18.46
3/31/15 17.07
12/31/14 16.80
Book Value
6/30/15 23.95
3/31/15 NA
12/31/14 28.35
Inventory Turnover
6/30/15 1.69
3/31/15 1.59
12/31/14 1.63
Debt-to-Equity
6/30/15 0.19
3/31/15 NA
12/31/14 0.24
Debt to Capital
6/30/15 15.94
3/31/15 NA
12/31/14 19.09